Resolution of acute gastroenteritis symptoms in children and adults treated with a novel polyphenol-based prebiotic

World Journal of Gastroenterology

Volumn 20, Issue 34, 2014, Pages 12301-12307

  Noguera, Telma ^a   Wotring, Robert ^b   Melville, Chris R ^b   Hargraves, Kara ^b   Kumm, Jochen ^c   Morton, John M ^d  

^a Instituto Centroamericano de Investigación Clínica   (Nicaragua)

^b Greenteaspoon Inc   (United States)

^c STANFORD UNIVERSITY   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aliva; Dehydration; Diarrhea; Gastroenteritis; Greenteaspoon; Heartburn; Infant mortality; Polyphenol; Prebiotic; Rotavirus

Indexed keywords

ALIVA; ANTIBIOTIC AGENT; BACTERIAL VACCINE; ORAL REHYDRATION SOLUTION; PLACEBO; POLYPHENOL DERIVATIVE; PREBIOTIC AGENT; UNCLASSIFIED DRUG; POLYPHENOL;

ACUTE GASTROENTERITIS; ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLOATING; CHILD; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; FECES ANALYSIS; FEMALE; HEARTBURN; HUMAN; INDIGESTION; MAJOR CLINICAL STUDY; MALE; OUTCOME VARIABLE; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; STOMACH DISCOMFORT; STOMACH PAIN; ABDOMINAL PAIN; ACUTE DISEASE; AGE; CLINICAL TRIAL; CONVALESCENCE; DEFECATION; FECES; FLATULENCE; GASTROENTERITIS; INTESTINE; MICROBIOLOGY; MULTICENTER STUDY; NICARAGUA; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ABDOMINAL PAIN; ACUTE DISEASE; ADOLESCENT; ADULT; AGE FACTORS; CHILD, PRESCHOOL; DEFECATION; DOUBLE-BLIND METHOD; FECES; FEMALE; FLATULENCE; GASTROENTERITIS; HUMANS; INTESTINES; MALE; NICARAGUA; POLYPHENOLS; PREBIOTICS; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84909606394     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i34.12301     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention. Viral Gastroenteritis. 2012 February 25, 2012 [cited 2013 February 3]. Available from: URL: http://www.cdc.gov/ncidod/dvrd/revb/gastro/faq.htm
2. Mayo Foundation for Medical Education and Research. Diarrhea. 2010 June 26 [cited 2013 February 3]. Available from: URL: http://www.mayoclinic.com/health/diarrhea/DS00292
3. World Health Organization. The treatment of diarrhoea: a manual for physicians and other senior health workers. Geneva, Switzerland; 1995. Available from: URL: http://www.who.int/chd/publications/cdd/textrev4.htm
4. Santosham M, Keenan EM, Tulloch J, Broun D, Glass R. Oral rehydration therapy for diarrhea: an example of reverse transfer of technology. Pediatrics 1997; 100: E10 [PMID: 9347004 DOI: 10.1542/peds.100.5.e10]
5. Thapar N, Sanderson IR. Diarrhoea in children: an interface between developing and developed countries. Lancet 2004; 363: 641-653 [PMID: 14987892 DOI: 10.1016/S0140-6736(04)15599-2]
6. King CK, Glass R, Bresee JS, Duggan C. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 2003; 52: 1-16 [PMID: 14627948 DOI: 10.1542/peds.114.2.507]
7. Elliott EJ. Acute gastroenteritis in children. BMJ 2007; 334: 35-40 [PMID: 17204802 DOI: 10.1136/bmj.39036.406169.80]
8. Snyder JD, Merson MH. The magnitude of the global problem of acute diarrhoeal disease: a review of active surveillance data. Bull World Health Organ 1982; 60: 605-613 [PMID: 6982783 DOI: 10.1016/b978-0-407-00401-6.50037-3]
9. Bern C, Martines J, de Zoysa I, Glass RI. The magnitude of the global problem of diarrhoeal disease: a ten-year update. Bull World Health Organ 1992; 70: 705-714 [PMID: 1486666]
10. Victora CG, Bryce J, Fontaine O, Monasch R. Reducing deaths from diarrhoea through oral rehydration therapy. Bull World Health Organ 2000; 78: 1246-1255 [PMID: 11100619]
11. World Health Organization. Diarrhoeal disease. 2009 August. Available from: URL: http://www.who.int/mediacentre/factsheets/fs330/en/index.html
12. Chow CM, Leung AK, Hon KL. Acute gastroenteritis: from guidelines to real life. Clin Exp Gastroenterol 2010; 3: 97-112 [PMID: 21694853 DOI: 10.2147/ceg.s6554]
13. Wood JD. Neuropathophysiology of functional gastrointestinal disorders. World J Gastroenterol 2007; 13: 1313-1332 [PMID: 17457962]
14. Casburn-Jones AC, Farthing MJ. Management of infectious diarrhoea. Gut 2004; 53: 296-305 [PMID: 14724167 DOI: 10.1136/gut.2003.022103]
15. Byarugaba DK. A view on antimicrobial resistance in developing countries and responsible risk factors. Int J Antimicrob Agents 2004; 24: 105-110 [PMID: 15288307 DOI: 10.1016/j.ijantimicag.2004.02.015]
16. Mackell S. Traveler's diarrhea in the pediatric population: etiology and impact. Clin Infect Dis 2005; 41 Suppl 8: S547-S552 [PMID: 16267717 DOI: 10.1086/432950]
17. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998; 11: 142-201 [PMID: 9457432]
18. Bines JE. Rotavirus vaccines and intussusception risk. Curr Opin Gastroenterol 2005; 21: 20-25 [PMID: 15687880]
19. Centers for Disease Control and Prevention. Rotavirus. 2012 November 9, 2012. Available from: URL: http://www.cdc.gov/vaccinesafety/vaccines/rotavsb.html
20. Babji S, Kang G. Rotavirus vaccination in developing countries. Curr Opin Virol 2012; 2: 443-448 [PMID: 22698800 DOI: 10.1016/j.coviro.2012.05.005]
21. Kaplan MA, Prior MJ, McKonly KI, DuPont HL, Temple AR, Nelson EB. A multicenter randomized controlled trial of a liquid loperamide product versus placebo in the treatment of acute diarrhea in children. Clin Pediatr (Phila) 1999; 38: 579-591 [PMID: 10544864 DOI: 10.1177/000992289903801003]